1-6 of 6
José María Ribera
Close
Sort by
Journal Articles

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Clinical Trials & Observations
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alberto López-García, Sylvain Lamure, Federico Itri, Maria Gomes-Silva, Giulia Dragonetti, Iker Falces-Romero, Jaap van Doesum, Uluhan Sili, Jorge Labrador, Maria Calbacho, Yavuz M. Bilgin, Barbora Weinbergerová, Laura Serrano, José-María Ribera-Santa Susana, Sandra Malak, José Loureiro-Amigo, Andreas Glenthøj, Raúl Córdoba-Mascuñano, Raquel Nunes-Rodrigues, Tomás-José González-López, Linda Katharina Karlsson, María-Josefa Jiménez-Lorenzo, José-Ángel Hernández-Rivas, Ozren Jaksic, Zdeněk Ráčil, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai Klimko, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Oliver A. Cornely
Journal: Blood
Blood (2022) 139 (10): 1588–1592.
https://doi.org/10.1182/blood.2021014124
Published: 2022
Includes: Supplemental data
Journal Articles

Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome

Brief Report
Carmen Muñiz, Lourdes Martín-Martín, Antonio López, Blanca Sánchez-González, Antonio Salar, Julia Almeida, Juan-Manuel Sancho, José María Ribera, Cecilia Heras, Francisco Javier Peñalver, Marta Gómez, Eva González-Barca, Natalia Alonso, Belén Navarro, Teresa Olave, Francisco Sala, Eulogio Conde, José Antonio Márquez, Elena Cabezudo, Antonia Cladera, María García-Malo, María Dolores Caballero, Alberto Orfao
Journal: Blood
Blood (2014) 123 (12): 1864–1869.
https://doi.org/10.1182/blood-2013-11-537993
Published: 2014
Includes: Supplemental data
Journal Articles

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

Clinical Trials & Observations
María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, Ana López de la Guía, Javier López, Enrique Bengoechea, Montserrat Pérez, Marta Polo, Luis Palomera, Felipe de Arriba, Yolanda González, Jose-Mariano Hernández, Miquel Granell, José-Luis Bello, Joan Bargay, Francisco-Javier Peñalver, José-María Ribera, María-Luisa Martín-Mateos, Ramón García-Sanz, Juan-José Lahuerta, Joan Bladé, Jesús F. San-Miguel
Journal: Blood
Blood (2012) 120 (13): 2581–2588.
https://doi.org/10.1182/blood-2012-05-427815
Published: 2012
Includes: Supplemental data
Journal Articles

Dasatinib (Sprycel®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Positive ALL: Results of the First 22 Patients Included in the EWALL-Ph-01 Trial (on Behalf of the European Working Group on Adult ALL (EWALL))

Philippe Rousselot, Jean-Michel Cayuela, Christian Recher, Thibaut Leguay, Célia Salanoubat, Francis Witz, Magda Alexis, Maud Janvier, Mathilde Hunault, Philippe Agape, Christian Berthou, Eric Jourdan, José Fernandes, Laurent Sutton, Anne Banos, Oumedaly Reman, Bruno Lioure, MD, Nicola Gökbuget, Dieter Hoelzer, MD, PhD, André Delannoy, Renato Bassan, Jose-Maria Ribera, Sebastian Giebel, Sandrine Hayette, Oliver Ottmann, Hervé Dombret
Journal: Blood
Blood (2008) 112 (11): 2920.
https://doi.org/10.1182/blood.V112.11.2920.2920
Published: 2008
Journal Articles

Effect of Pre and Post-Transplantation Responses on Outcome of Multiple Myeloma Patients: CR and near-CR Should Not Be Considered as Equivalent Prognostic Markers. Results of a PETHEMA/Gem Prospective Study

Juan José Lahuerta, Maria Victoria Mateos, Joaquin Martínez-López, Laura Rosinol, Anna Sureda, Javier de la Rubia, José García-Laraña, Rafael Martínez-Martínez, Miguel-Teodoro Hernández-García, Dolores Carrera, Juan Besalduch, MD, PhD, Felipe de Arriba, Jose-Maria Ribera, Lourdes Escoda, María-Belen Hernández-Ruiz, Javier García-Frade, Concepción Rivas-González, Adrian Alegre, Joan Blade, J.F. San Miguel
Journal: Blood
Blood (2008) 112 (11): 161.
https://doi.org/10.1182/blood.V112.11.161.161
Published: 2008
Journal Articles

Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.

Jose Rodriguez, Maria Dolores Caballero, Antonio Gutierrez, Marco Gandarillas, Angel Leon, Jesus Ojanguren, Ana Sureda, Armando Lopez-Guillermo, Dolores Carrera, Mauricio Bendandi, Reyes Arranz, Jose Moraleda, Jose Maria Ribera, Carmen Albo, Alfonso Morales, Juan Carlos Garcia, Pascual Fernandez, Guillermo Cañigral, Juan Bergua, Eulogio Conde
Journal: Blood
Blood (2005) 106 (11): 2082.
https://doi.org/10.1182/blood.V106.11.2082.2082
Published: 2005